PA
BPMC
Profund Advisors’s Blueprint Medicines BPMC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.69M | Sell |
13,210
-7,630
| -37% | -$978K | 0.06% | 208 |
|
2025
Q1 | $1.84M | Buy |
20,840
+3,094
| +17% | +$274K | 0.08% | 193 |
|
2024
Q4 | $1.55M | Sell |
17,746
-5,704
| -24% | -$498K | 0.06% | 220 |
|
2024
Q3 | $2.17M | Buy |
23,450
+5,336
| +29% | +$494K | 0.08% | 177 |
|
2024
Q2 | $1.95M | Buy |
18,114
+1,739
| +11% | +$187K | 0.07% | 181 |
|
2024
Q1 | $1.55M | Sell |
16,375
-4,253
| -21% | -$403K | 0.06% | 217 |
|
2023
Q4 | $1.9M | Sell |
20,628
-8,035
| -28% | -$741K | 0.08% | 180 |
|
2023
Q3 | $1.44M | Buy |
28,663
+2,225
| +8% | +$112K | 0.08% | 196 |
|
2023
Q2 | $1.67M | Sell |
26,438
-4,162
| -14% | -$263K | 0.09% | 180 |
|
2023
Q1 | $1.38M | Buy |
30,600
+22,502
| +278% | +$1.01M | 0.09% | 202 |
|
2022
Q4 | $355K | Buy |
8,098
+170
| +2% | +$7.45K | 0.02% | 556 |
|
2022
Q3 | $522K | Sell |
7,928
-149
| -2% | -$9.81K | 0.04% | 376 |
|
2022
Q2 | $408K | Sell |
8,077
-985
| -11% | -$49.8K | 0.03% | 494 |
|
2022
Q1 | $579K | Sell |
9,062
-1,008
| -10% | -$64.4K | 0.02% | 479 |
|
2021
Q4 | $1.08M | Sell |
10,070
-1,141
| -10% | -$122K | 0.04% | 310 |
|
2021
Q3 | $1.15M | Sell |
11,211
-464
| -4% | -$47.7K | 0.04% | 312 |
|
2021
Q2 | $1.03M | Sell |
11,675
-227
| -2% | -$20K | 0.03% | 356 |
|
2021
Q1 | $1.16M | Sell |
11,902
-635
| -5% | -$61.7K | 0.04% | 278 |
|
2020
Q4 | $1.41M | Buy |
12,537
+1,276
| +11% | +$143K | 0.06% | 250 |
|
2020
Q3 | $1.04M | Sell |
11,261
-1,649
| -13% | -$153K | 0.05% | 271 |
|
2020
Q2 | $1.01M | Buy |
12,910
+2,925
| +29% | +$228K | 0.06% | 269 |
|
2020
Q1 | $584K | Sell |
9,985
-4,093
| -29% | -$239K | 0.04% | 321 |
|
2019
Q4 | $1.13M | Buy |
14,078
+1,749
| +14% | +$140K | 0.05% | 319 |
|
2019
Q3 | $906K | Buy |
+12,329
| New | +$906K | 0.05% | 349 |
|